Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.

Hdl Handle:
http://hdl.handle.net/10144/255332
Title:
Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.
Authors:
Sabapathy, Kalpana; Ford, Nathan; Chan, Khin Nyein; Kyaw, Moe Kyaw; Elema, Riekje; Smithuis, Frank; Floyd, Sian
Journal:
Journal of Acquired Immune Deficiency Syndromes
Abstract:
Antiretroviral treatment (ART) coverage in Myanmar is well below average. This study describes retention and baseline predictors of prognosis from the largest ART program in the country.
Affiliation:
Imperial College London, London, United Kingdom; Medecins Sans Frontieres, Amsterdam, The Netherlands, Medecins Sans Frontieres, Geneva, Switzerland; Medecisn Sans Frontieres, Yangon, Myanmar; Medical Action Myanmar, Yangon, Myanmar; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Issue Date:
1-Jun-2012
URI:
http://hdl.handle.net/10144/255332
DOI:
10.1097/QAI.0b013e31824d5689
PubMed ID:
22334069
Type:
Article
Language:
en
Description:
Article approval pending
ISSN:
1944-7884
Appears in Collections:
HIV/AIDS

Full metadata record

DC FieldValue Language
dc.contributor.authorSabapathy, Kalpanaen_GB
dc.contributor.authorFord, Nathanen_GB
dc.contributor.authorChan, Khin Nyeinen_GB
dc.contributor.authorKyaw, Moe Kyawen_GB
dc.contributor.authorElema, Riekjeen_GB
dc.contributor.authorSmithuis, Franken_GB
dc.contributor.authorFloyd, Sianen_GB
dc.date.accessioned2012-12-11T20:05:32Z-
dc.date.available2012-12-11T20:05:32Z-
dc.date.issued2012-06-01-
dc.identifier.citationJ Acquir Immune Defic Syndr 2012; 60 (2):e53-62en_GB
dc.identifier.issn1944-7884-
dc.identifier.pmid22334069-
dc.identifier.doi10.1097/QAI.0b013e31824d5689-
dc.identifier.urihttp://hdl.handle.net/10144/255332-
dc.descriptionArticle approval pendingen_GB
dc.description.abstractAntiretroviral treatment (ART) coverage in Myanmar is well below average. This study describes retention and baseline predictors of prognosis from the largest ART program in the country.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Journal of Acquired Immune Deficiency Syndromes (1999)en_GB
dc.subjectHIV/AIDSen_GB
dc.subjectclosed accessen_GB
dc.subject.meshAdulten_GB
dc.subject.meshAnti-HIV Agentsen_GB
dc.subject.meshAntiretroviral Therapy, Highly Activeen_GB
dc.subject.meshCohort Studiesen_GB
dc.subject.meshFemaleen_GB
dc.subject.meshFollow-Up Studiesen_GB
dc.subject.meshHIV Infectionsen_GB
dc.subject.meshHumansen_GB
dc.subject.meshMaleen_GB
dc.subject.meshMedication Adherenceen_GB
dc.subject.meshMyanmaren_GB
dc.subject.meshTreatment Outcomeen_GB
dc.titleTreatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.en
dc.typeArticleen
dc.contributor.departmentImperial College London, London, United Kingdom; Medecins Sans Frontieres, Amsterdam, The Netherlands, Medecins Sans Frontieres, Geneva, Switzerland; Medecisn Sans Frontieres, Yangon, Myanmar; Medical Action Myanmar, Yangon, Myanmar; London School of Hygiene and Tropical Medicine, London, United Kingdom.en_GB
dc.identifier.journalJournal of Acquired Immune Deficiency Syndromesen_GB

Related articles on PubMed

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.